Immix Biopharma, Inc.
IMMX
$1.95
-$0.08-3.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.81M | -7.15M | -4.39M | -5.26M | -5.09M |
| Total Depreciation and Amortization | 41.30K | 25.90K | 24.30K | 23.90K | 3.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 705.70K | 733.80K | 624.90K | 871.20K | 984.90K |
| Change in Net Operating Assets | 2.59M | 2.35M | -1.51M | 537.10K | 1.42M |
| Cash from Operations | -1.48M | -4.04M | -5.26M | -3.83M | -2.68M |
| Capital Expenditure | -507.20K | -271.50K | -97.10K | -301.90K | -13.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -507.20K | -271.50K | -97.10K | -301.90K | -13.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 15.95M | 586.70K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 15.95M | 586.70K |
| Foreign Exchange rate Adjustments | -25.10K | 23.00K | 8.90K | -10.40K | 31.30K |
| Miscellaneous Cash Flow Adjustments | 0.00 | -- | -- | -- | -- |
| Net Change in Cash | -2.01M | -4.28M | -5.34M | 11.81M | -2.07M |